Open Science can be best defined as the practice of freely sharing clinical and scientific knowledge such that others can collaborate and build upon that knowledge to accelerate research applications. Within this Open Science ecosystem, clinical data sharing, and data transparency continue to advance. Many national and international organisations such as the National Institutes of Health and the UK’s Medical Research Council, are adopting open data policies. But barriers remain.
This episode was part of a podcast series funded by Pfizer to celebrate 2021 International Open Access Week. The series interviewed experts working within clinical and medical disciplines who shared their perspectives on the impact and benefit of open science for patients and key stakeholders.
This podcast's guest is Dr Joseph Ross, Professor of Medicine and of Public Health at the Yale-New Haven Hospital. Dr Ross co-directs the Yale-Mayo Clinic Center for Excellence in Regulatory Science and Innovation, the Yale Open Data Access (YODA) Project, the Collaboration for Research Integrity and Transparency at Yale Law School and leads efforts at Yale-New Haven Health System in collaboration with the National Evaluation System for health Technology. Dr Ross is also currently the U.S. Outreach and Research Editor at BMJ.
Disclosure: Inspiring STEM Consulting Limited received funding from Pfizer. None of the podcast participants received funding or were contracted to speak. This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International (CC BY-SA 4.0) licence https://creativecommons.org/licenses/by-sa/4.0/